Results 151 to 160 of about 9,073,815 (290)

Traube & Piorkowsky, Damen- u. Kinder-Konfektion, Kaiserstrasse 40, Frankfurt a. Main, Wüsten & Co. Frankfurt a. M.

TRAUBE & PIORKOWSKY, DAMEN- U. KINDER-KONFEKTION, KAISERSTRASSE 40, FRANKFURT A. MAIN, WÜSTEN & CO. FRANKFURT A. M. Traube & Piorkowsky, Damen- u. Kinder-Konfektion, Kaiserstrasse 40, Frankfurt a. Main, Wüsten & Co. Frankfurt a. M. ( -
Wüsten & Co. Frankfurt a. M., Traube & Piorkowsky   +1 more
core  

Green Versus Sustainable Loans: The Impact on Firms' ESG Performance

European Financial Management, EarlyView.
ABSTRACT This paper studies the development of a firm's Environmental, Social, and Governance (ESG) performance following the issuance of “green loans” earmarked for green projects versus “sustainable loans” benchmarked by ESG criteria. Firms issuing green loans improve environmental performance, particularly by reducing emissions, but experience ...
H. Özlem Dursun‐de Neef, Steven Ongena, Gergana Tsonkova   +2 more
wiley   +1 more source

Pitfalls in 2HG Detection With TE-Optimized MRS at 3T. [PDF]

J Neuroimaging
Alcicek S, Simicic D, Blair L, Saint-Germain M, Zöllner HJ, Davies-Jenkins CW, Holdhoff M, Laterra J, Bettegowda C, Schreck KC, Lin DD, Barker PB, Kamson DO, Oeltzschner G.   +13 more
europepmc   +1 more source

... Jahresbericht der Jüdischen Frauenvereinigung e.V. zu Frankfurt a.M.

, 2018
1. (29. Oktober 1907/31. Dezember 1908)-8. (1915) ; [13. (1920)] -14. (1921) [?]Einmalige Beilage: Satzungen des Jüdischen Frauenvereins e.V. zu Frankfurt a.M.Verfasser 1. (29. Oktober 1907/31. Dezember 1908): Jüdischer Frauenverein e.V. zu Frankfurt a.M.
Jüdische Frauenvereinigung e.V. zu Frankfurt a. M.
core  

Contrasting Approaches in the Implementation of GRADE Methodology in Guidelines for Haemophilia and Von Willebrand Disease

Haemophilia, EarlyView.
ABSTRACT Introduction The 2024 ISTH clinical practice guideline (CPG) for treatment of congenital haemophilia, the NBDF‐McMaster Guideline on Care Models for Haemophilia Management, and ASH ISTH NBDF WFH guidelines on the diagnosis and management of VWD all utilised GRADE methodology.
Mark W. Skinner, Manuela Albisetti, Jesús Ardila, Jan Astermark, Jan Blatny, Manuel Carcao, Pratima Chowdary, Nathan T. Connell, Miguel Crato, Yesim Dargaud, Roseline d'Oiron, Amy L. Dunn, Miguel A. Escobar, Carmen Escuriola‐Ettingshausen, Emna Gouider, Annie Harroche, Cedric Hermans, Victor Jimenez‐Yuste, Radoslaw Kaczmarek, Gili Kenet, Liane Khoo, Robert Klamroth, Florian Langer, David Lillicrap, Johnny Mahlangu, Christoph Male, Tadashi Matsushita, Sandrine Meunier, Wolfgang Miesbach, Beatrice Nolan, Johannes Oldenburg, Brian O'Mahony, Margareth Ozelo, Glenn F. Pierce, Gloria Ramos, Michael Recht, Olivia Romero‐Lux, Dawn Rotellini, Rita C. Santoro, Tammuella C. Singleton, Alok Srivastava, Sophie Susen, Kate Talks, Huyen Tran, Leonard A. Valentino, Jerzy Windyga, Renchi Yang, Maria Elisa Mancuso, also on behalf of AICE, AHAD‐AP, AHCDC, ATHN, CLAHT, EHC, French CRH & MHEMO, HTCCNC, NBDF, PEDNET, UKHCDO, WFH   +59 more
wiley   +1 more source

Quality of life with nivolumab and AVD first-line treatment of Hodgkin lymphoma in the Phase II GHSG NIVAHL trial. [PDF]

Hemasphere
Jaworek CP, Bühnen I, Herhaus P, Meissner J, Trautmann-Grill K, Halbsguth T, Kerkhoff A, Schaub V, Fuchs M, von Tresckow B, Borchmann P, Behringer K, Bröckelmann PJ.   +12 more
europepmc   +1 more source

Bringing Gene Therapy Into Real World Clinical Practice

Haemophilia, EarlyView.
ABSTRACT Introduction Adeno‐associated virus (AAV)‐based gene therapy for haemophilia has shifted therapeutic paradigms by enabling hepatic gene transfer, restoring endogenous clotting factor expression, and reducing reliance on conventional prophylactic treatments. Two products, valoctocogene roxaparvovec (haemophilia A) and etranacogene dezaparvovec (
Wolfgang Miesbach, Pratima Chowdary, Margareth C. Ozelo   +2 more
wiley   +1 more source

Real‐World Outcomes of Prophylaxis With rIX‐FP in Germany: A Prospective, Non‐Interventional Study in Haemophilia B

Haemophilia, EarlyView.
ABSTRACT Introduction Efficacy and safety of albutrepenonacog alfa (rIX‐FP) in people with haemophilia B (PwHB) has been previously demonstrated in clinical trials. However, real‐world data insights are required. Aim To describe real‐world effectiveness and tolerability of rIX‐FP in PwHB in Germany.
Johannes Oldenburg, Swee Wenning, Susanne Holzhauer, Wolfgang Miesbach, Robert Klamroth, Thomas Linhoff, Patrick Sommerer, Christian Pfrepper, Martin Olivieri, all study investigators   +9 more
wiley   +1 more source

Uneven attention to climate tipping points. [PDF]

Proc Natl Acad Sci U S A
Wang H, Chen B, Ma F, Wunderling N, Lenton TM, Tzachor A.   +5 more
europepmc   +1 more source

A Common Language for the Multidisciplinary Team: Point‐of‐Care Musculoskeletal Ultrasound in Modern Haemophilia Care

Haemophilia, EarlyView.
ABSTRACT The evolving haemophilia care landscape has evolved with personalised prophylaxis, new coagulation factor molecules, non‐replacement therapies, and gene therapy, leading to significantly reduced bleeding frequency and haemophilic arthropathy burden.
Hortensia De la Corte‐Rodriguez, María Teresa Álvarez‐Román, Mauro Davoli, Magnus Aspdahl, Christina Burgess, Karin Fijinvandraat, Roberta Gualtierotti, Cedric Hermans, Marko Marinić, Carlo Martinoli, Wolfgang Miesbach, Gianluigi Pasta, Michael Sigl‐Kraetzig, David Stephensen, Malin Svennefalk, Víctor Jiménez‐Yuste, the E.A.H.A.D. Joint Health Group   +16 more
wiley   +1 more source